Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
Provided By GlobeNewswire
Last update: Jul 23, 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, announced today that the Company’s management will participate in the BTIG Virtual Biotechnology Conference being held on July 29-30, 2025.
Read more at globenewswire.com
